GE HealthCare (NASDAQ:GEHC) Q2 Adjusted Earnings Fall, Revenue Rises

/ / Health Care /

GE HealthCare Technologies (NASDAQ:GEHC) reported Q2 adjusted earnings  of $0.92 per diluted share, down from $1.15 a year earlier. Analysts polled by Capital IQ expected $0.87. Revenue for the quarter ended June 30 was $4.82 billion, compared with $4.48 billion a year ago. Analysts surveyed by Capital IQ expected $4.79 billion. The company said it expects full-year 2023 adjusted earnings of $3.70 to $3.85 per diluted share, compared with $3.60 to $3.75 anticipated previously. Analysts polled by Capital IQ expect $3.74.

GE HealthCare (NASDAQ:GEHC) Q2 Adjusted Earnings Fall, Revenue Rises Read Post »

Northrop Grumman (NYSE:NOC) Q2 Earnings Fall, Sales Rise; 2023 Guidance Revised

/ / Industrials /

Northrop Grumman (NYSE:NOC) reported Q2 earnings  of $5.34 per diluted share, down from $6.06 a year earlier. Analysts polled by Capital IQ expected $5.34. Sales for the quarter ended June 30 were $9.58 billion, up from $8.8 billion a year earlier. Analysts surveyed by Capital IQ expected $9.34 billion. The defense contractor said it now expects 2023 adjusted EPS of $22.45 to $22.85, compared with its prior guidance of between $22.25 and $22.85. Analysts polled by Capital IQ expect $22.61. Sales for 2023 are now expected to range between $38.4 billion and $38.8 billion, up from the company’s earlier forecast of $38 billion to $38.40 billion. Analysts surveyed by Capital IQ expect $38.39 billion.

Northrop Grumman (NYSE:NOC) Q2 Earnings Fall, Sales Rise; 2023 Guidance Revised Read Post »

Scroll to Top